Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti‐PD‐1 antibodies

Author:

Pires da Silva Ines1ORCID,Glitza Isabella C.2ORCID,Haydu Lauren E.2,Johnpulle Romany3,Banks Patricia D.4,Grass George D.5,Goldinger Simone M. A.6,Smith Jessica L.7,Everett Ashlyn S.8,Koelblinger Peter9,Roberts‐Thomson Rachel10,Millward Michael1112,Atkinson Victoria G.13,Guminski Alexander114,Kapoor Rony1,Conry Robert M.8,Carlino Matteo S.17,Wang Wei17,Shackleton Mark J.41516,Eroglu Zeynep5,Lo Serigne1ORCID,Hong Angela M.1,Long Georgina V.114,Johnson Douglas B.3ORCID,Menzies Alexander M.114

Affiliation:

1. Melanoma Institute Australia and The University of Sydney Sydney New South Wales Australia

2. The University of Texas MD Anderson Cancer Center Houston Texas

3. Vanderbilt University Medical Center Nashville Tennessee

4. Peter MacCallum Cancer Centre Melbourne Victoria Australia

5. H. Lee Moffitt Cancer Center and Research Institute Tampa Florida

6. University Hospital Zurich Zurich Switzerland

7. Crown Princess Mary Cancer Centre, Westmead Hospital Sydney New South Wales Australia

8. University of Alabama at Birmingham Birmingham Alabama

9. Paracelsus Medical University Salzburg Austria

10. The Queen Elizabeth Hospital Woodville South South Australia Australia

11. School of Medicine University of Western Australia Perth Western Australia Australia

12. Department of Medical Oncology Sir Charles Gairdner Hospital Perth Western Australia Australia

13. Princess Alexandra Hospital and Greenslopes Private Hospital University of Queensland Brisbane Queensland Australia

14. Royal North Shore and Mater Hospitals Sydney New South Wales Australia

15. Central Clinical School, Faculty of Medicine, Nursing and Health Sciences Monash University Melbourne Victoria Australia

16. Department of Oncology Alfred Health Melbourne Victoria Australia

Funder

Cancer Institute NSW

Victorian Cancer Agency

Publisher

Wiley

Subject

Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology

Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3